Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 2025

BOULDER, Colo.–(BUSINESS WIRE)–Watchmaker Genomics launches TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks